nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—Diphenhydramine—atopic dermatitis	0.287	1	CrCtD
Fentanyl—prostate cancer—Hydrocortisone—atopic dermatitis	0.119	0.45	CpDpCtD
Fentanyl—prostate cancer—Betamethasone—atopic dermatitis	0.0728	0.275	CpDpCtD
Fentanyl—prostate cancer—Dexamethasone—atopic dermatitis	0.0728	0.275	CpDpCtD
Fentanyl—Benzatropine—Dimenhydrinate—atopic dermatitis	0.023	0.111	CrCrCtD
Fentanyl—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.0186	0.116	CbGbCtD
Fentanyl—CYP3A7—Tacrolimus—atopic dermatitis	0.0186	0.116	CbGbCtD
Fentanyl—Diphenylpyraline—Dimenhydrinate—atopic dermatitis	0.0162	0.0787	CrCrCtD
Fentanyl—Modafinil—Dimenhydrinate—atopic dermatitis	0.0159	0.0769	CrCrCtD
Fentanyl—Bepridil—Diphenhydramine—atopic dermatitis	0.0148	0.0719	CrCrCtD
Fentanyl—Cyclizine—Dimenhydrinate—atopic dermatitis	0.0146	0.0705	CrCrCtD
Fentanyl—CYP3A5—Tacrolimus—atopic dermatitis	0.014	0.0873	CbGbCtD
Fentanyl—Phenylbutazone—Diphenhydramine—atopic dermatitis	0.0123	0.0595	CrCrCtD
Fentanyl—Alverine—Diphenhydramine—atopic dermatitis	0.0118	0.0571	CrCrCtD
Fentanyl—Benzatropine—Diphenhydramine—atopic dermatitis	0.0109	0.0529	CrCrCtD
Fentanyl—Diphenhydramine—Dimenhydrinate—atopic dermatitis	0.0106	0.0513	CrCrCtD
Fentanyl—Eprazinone—Diphenhydramine—atopic dermatitis	0.0102	0.0493	CrCrCtD
Fentanyl—Antazoline—Diphenhydramine—atopic dermatitis	0.0102	0.0493	CrCrCtD
Fentanyl—CYP3A4—Pimecrolimus—atopic dermatitis	0.00915	0.0573	CbGbCtD
Fentanyl—ABCB1—Tacrolimus—atopic dermatitis	0.00909	0.0568	CbGbCtD
Fentanyl—Dextropropoxyphene—Diphenhydramine—atopic dermatitis	0.00809	0.0392	CrCrCtD
Fentanyl—Phenoxybenzamine—Diphenhydramine—atopic dermatitis	0.00809	0.0392	CrCrCtD
Fentanyl—Diphenylpyraline—Diphenhydramine—atopic dermatitis	0.00771	0.0373	CrCrCtD
Fentanyl—CYP3A7—Hydrocortisone—atopic dermatitis	0.00758	0.0474	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.00758	0.0474	CbGbCtD
Fentanyl—Modafinil—Diphenhydramine—atopic dermatitis	0.00753	0.0365	CrCrCtD
Fentanyl—Cyclizine—Diphenhydramine—atopic dermatitis	0.00691	0.0335	CrCrCtD
Fentanyl—Methadone—Diphenhydramine—atopic dermatitis	0.00677	0.0328	CrCrCtD
Fentanyl—ABCB1—Loratadine—atopic dermatitis	0.00665	0.0416	CbGbCtD
Fentanyl—ABCB1—Methylprednisolone—atopic dermatitis	0.00608	0.0381	CbGbCtD
Fentanyl—CYP3A5—Hydrocortisone—atopic dermatitis	0.00568	0.0356	CbGbCtD
Fentanyl—Benzphetamine—Diphenhydramine—atopic dermatitis	0.00566	0.0274	CrCrCtD
Fentanyl—CYP3A4—Tacrolimus—atopic dermatitis	0.00544	0.0341	CbGbCtD
Fentanyl—Benzyl Benzoate—Diphenhydramine—atopic dermatitis	0.00525	0.0254	CrCrCtD
Fentanyl—CYP3A7—Dexamethasone—atopic dermatitis	0.00471	0.0295	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.00471	0.0295	CbGbCtD
Fentanyl—CYP3A4—Loratadine—atopic dermatitis	0.00398	0.0249	CbGbCtD
Fentanyl—ABCB1—Betamethasone—atopic dermatitis	0.00395	0.0247	CbGbCtD
Fentanyl—ABCB1—Prednisolone—atopic dermatitis	0.0039	0.0244	CbGbCtD
Fentanyl—ABCB1—Hydrocortisone—atopic dermatitis	0.0037	0.0231	CbGbCtD
Fentanyl—ABCB1—Prednisone—atopic dermatitis	0.00369	0.0231	CbGbCtD
Fentanyl—CYP3A4—Methylprednisolone—atopic dermatitis	0.00364	0.0228	CbGbCtD
Fentanyl—CYP3A5—Dexamethasone—atopic dermatitis	0.00353	0.0221	CbGbCtD
Fentanyl—CYP3A4—Triamcinolone—atopic dermatitis	0.00276	0.0173	CbGbCtD
Fentanyl—CYP3A4—Betamethasone—atopic dermatitis	0.00237	0.0148	CbGbCtD
Fentanyl—CYP3A4—Prednisolone—atopic dermatitis	0.00234	0.0146	CbGbCtD
Fentanyl—ABCB1—Dexamethasone—atopic dermatitis	0.0023	0.0144	CbGbCtD
Fentanyl—CYP3A4—Hydrocortisone—atopic dermatitis	0.00222	0.0139	CbGbCtD
Fentanyl—CYP3A4—Prednisone—atopic dermatitis	0.00221	0.0138	CbGbCtD
Fentanyl—CYP3A4—Dexamethasone—atopic dermatitis	0.00138	0.00862	CbGbCtD
Fentanyl—ABCB1—Allograft Rejection—IL5—atopic dermatitis	3.22e-05	0.00372	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	3.22e-05	0.00371	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—CCL17—atopic dermatitis	3.19e-05	0.00369	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—CCL11—atopic dermatitis	3.05e-05	0.00352	CbGpPWpGaD
Fentanyl—OPRD1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	3.04e-05	0.00351	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—CXCR3—atopic dermatitis	3.03e-05	0.0035	CbGpPWpGaD
Fentanyl—OPRK1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	2.96e-05	0.00341	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	2.91e-05	0.00336	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	2.91e-05	0.00336	CbGpPWpGaD
Fentanyl—OPRM1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	2.9e-05	0.00335	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—CXCL10—atopic dermatitis	2.9e-05	0.00335	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	2.85e-05	0.00329	CbGpPWpGaD
Fentanyl—OPRD1—G alpha (i) signalling events—CCL5—atopic dermatitis	2.85e-05	0.00329	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—CCR3—atopic dermatitis	2.83e-05	0.00327	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	2.81e-05	0.00325	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CCL22—atopic dermatitis	2.77e-05	0.0032	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	2.76e-05	0.00318	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—CCL27—atopic dermatitis	2.72e-05	0.00314	CbGpPWpGaD
Fentanyl—OPRK1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	2.66e-05	0.00308	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	2.63e-05	0.00303	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—CCL11—atopic dermatitis	2.58e-05	0.00297	CbGpPWpGaD
Fentanyl—OPRM1—TCR Signaling Pathway—CD4—atopic dermatitis	2.57e-05	0.00297	CbGpPWpGaD
Fentanyl—OPRD1—G alpha (i) signalling events—CCR5—atopic dermatitis	2.56e-05	0.00296	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—TAC1—atopic dermatitis	2.52e-05	0.00291	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—NPS—atopic dermatitis	2.52e-05	0.00291	CbGpPWpGaD
Fentanyl—OPRM1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	2.5e-05	0.00289	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—CCL5—atopic dermatitis	2.49e-05	0.00288	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—CCR3—atopic dermatitis	2.48e-05	0.00287	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—CXCR3—atopic dermatitis	2.48e-05	0.00286	CbGpPWpGaD
Fentanyl—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	2.47e-05	0.00285	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CCL27—atopic dermatitis	2.47e-05	0.00285	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	2.46e-05	0.00284	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	2.46e-05	0.00284	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—CXCL10—atopic dermatitis	2.45e-05	0.00283	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CCL22—atopic dermatitis	2.43e-05	0.0028	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	2.41e-05	0.00278	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CCL27—atopic dermatitis	2.38e-05	0.00275	CbGpPWpGaD
Fentanyl—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	2.38e-05	0.00275	CbGpPWpGaD
Fentanyl—OPRM1—TCR Signaling Pathway—IL1B—atopic dermatitis	2.37e-05	0.00274	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—IL10—atopic dermatitis	2.36e-05	0.00272	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	2.3e-05	0.00266	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—IL4—atopic dermatitis	2.29e-05	0.00265	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	2.26e-05	0.00261	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	2.25e-05	0.0026	CbGpPWpGaD
Fentanyl—OPRM1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	2.25e-05	0.0026	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—CCR5—atopic dermatitis	2.25e-05	0.0026	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—TAC1—atopic dermatitis	2.21e-05	0.00256	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—NPS—atopic dermatitis	2.21e-05	0.00256	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CCL17—atopic dermatitis	2.21e-05	0.00255	CbGpPWpGaD
Fentanyl—OPRM1—TCR Signaling Pathway—MAPK8—atopic dermatitis	2.18e-05	0.00251	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—CXCR3—atopic dermatitis	2.17e-05	0.00251	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CCL27—atopic dermatitis	2.16e-05	0.0025	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—CCL5—atopic dermatitis	2.11e-05	0.00243	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—CCR3—atopic dermatitis	2.1e-05	0.00242	CbGpPWpGaD
Fentanyl—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	2.09e-05	0.00241	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CCL22—atopic dermatitis	2.05e-05	0.00237	CbGpPWpGaD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.04e-05	0.00235	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CCL27—atopic dermatitis	2.01e-05	0.00232	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—CXCL10—atopic dermatitis	2e-05	0.00231	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	1.98e-05	0.00229	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	1.95e-05	0.00225	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CCL17—atopic dermatitis	1.94e-05	0.00224	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—CCR5—atopic dermatitis	1.9e-05	0.00219	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—NPS—atopic dermatitis	1.87e-05	0.00216	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—TAC1—atopic dermatitis	1.87e-05	0.00216	CbGpPWpGaD
Fentanyl—OPRD1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	1.84e-05	0.00212	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—CXCR3—atopic dermatitis	1.83e-05	0.00212	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CCL27—atopic dermatitis	1.83e-05	0.00211	CbGpPWpGaD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.79e-05	0.00206	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CCL11—atopic dermatitis	1.78e-05	0.00206	CbGpPWpGaD
Fentanyl—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	1.76e-05	0.00204	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—FCER2—atopic dermatitis	1.76e-05	0.00203	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—CXCL10—atopic dermatitis	1.75e-05	0.00203	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—CCL5—atopic dermatitis	1.72e-05	0.00199	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	1.68e-05	0.00194	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CCL17—atopic dermatitis	1.64e-05	0.00189	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCL22—atopic dermatitis	1.63e-05	0.00189	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	1.63e-05	0.00188	CbGpPWpGaD
Fentanyl—OPRK1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	1.61e-05	0.00186	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—CCR3—atopic dermatitis	1.6e-05	0.00185	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CCL11—atopic dermatitis	1.56e-05	0.00181	CbGpPWpGaD
Fentanyl—Anaphylactic shock—Hydrocortisone—atopic dermatitis	1.56e-05	0.000214	CcSEcCtD
Fentanyl—Convulsion—Triamcinolone—atopic dermatitis	1.56e-05	0.000214	CcSEcCtD
Fentanyl—Tachycardia—Prednisolone—atopic dermatitis	1.56e-05	0.000214	CcSEcCtD
Fentanyl—Convulsion—Methylprednisolone—atopic dermatitis	1.56e-05	0.000213	CcSEcCtD
Fentanyl—Hypertension—Triamcinolone—atopic dermatitis	1.56e-05	0.000213	CcSEcCtD
Fentanyl—Hypertension—Methylprednisolone—atopic dermatitis	1.55e-05	0.000213	CcSEcCtD
Fentanyl—Infection—Hydrocortisone—atopic dermatitis	1.55e-05	0.000213	CcSEcCtD
Fentanyl—OPRD1—GPCR ligand binding—CCR5—atopic dermatitis	1.55e-05	0.00179	CbGpPWpGaD
Fentanyl—OPRD1—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.55e-05	0.00179	CbGpPWpGaD
Fentanyl—Hyperhidrosis—Prednisolone—atopic dermatitis	1.55e-05	0.000212	CcSEcCtD
Fentanyl—OPRK1—Signaling Pathways—FCER2—atopic dermatitis	1.54e-05	0.00178	CbGpPWpGaD
Fentanyl—Shock—Hydrocortisone—atopic dermatitis	1.54e-05	0.000211	CcSEcCtD
Fentanyl—Myalgia—Triamcinolone—atopic dermatitis	1.53e-05	0.00021	CcSEcCtD
Fentanyl—Nervous system disorder—Hydrocortisone—atopic dermatitis	1.53e-05	0.00021	CcSEcCtD
Fentanyl—Arthralgia—Methylprednisolone—atopic dermatitis	1.53e-05	0.00021	CcSEcCtD
Fentanyl—Myalgia—Methylprednisolone—atopic dermatitis	1.53e-05	0.00021	CcSEcCtD
Fentanyl—Eye disorder—Prednisone—atopic dermatitis	1.53e-05	0.000209	CcSEcCtD
Fentanyl—Anxiety—Methylprednisolone—atopic dermatitis	1.53e-05	0.000209	CcSEcCtD
Fentanyl—Tachycardia—Hydrocortisone—atopic dermatitis	1.52e-05	0.000209	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	1.52e-05	0.000208	CcSEcCtD
Fentanyl—Flushing—Prednisone—atopic dermatitis	1.52e-05	0.000208	CcSEcCtD
Fentanyl—Skin disorder—Hydrocortisone—atopic dermatitis	1.52e-05	0.000208	CcSEcCtD
Fentanyl—Ill-defined disorder—Dexamethasone—atopic dermatitis	1.52e-05	0.000208	CcSEcCtD
Fentanyl—Ill-defined disorder—Betamethasone—atopic dermatitis	1.52e-05	0.000208	CcSEcCtD
Fentanyl—Discomfort—Triamcinolone—atopic dermatitis	1.52e-05	0.000208	CcSEcCtD
Fentanyl—Discomfort—Methylprednisolone—atopic dermatitis	1.51e-05	0.000207	CcSEcCtD
Fentanyl—OPRK1—GPCR ligand binding—CCL5—atopic dermatitis	1.51e-05	0.00174	CbGpPWpGaD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.51e-05	0.00174	CbGpPWpGaD
Fentanyl—Hyperhidrosis—Hydrocortisone—atopic dermatitis	1.51e-05	0.000207	CcSEcCtD
Fentanyl—Dry mouth—Triamcinolone—atopic dermatitis	1.5e-05	0.000206	CcSEcCtD
Fentanyl—Anorexia—Hydrocortisone—atopic dermatitis	1.49e-05	0.000204	CcSEcCtD
Fentanyl—Nausea—Tacrolimus—atopic dermatitis	1.49e-05	0.000204	CcSEcCtD
Fentanyl—Angiopathy—Prednisone—atopic dermatitis	1.48e-05	0.000203	CcSEcCtD
Fentanyl—OPRM1—GPCR ligand binding—CXCL10—atopic dermatitis	1.48e-05	0.00171	CbGpPWpGaD
Fentanyl—Confusional state—Methylprednisolone—atopic dermatitis	1.48e-05	0.000203	CcSEcCtD
Fentanyl—Immune system disorder—Prednisone—atopic dermatitis	1.48e-05	0.000202	CcSEcCtD
Fentanyl—Malaise—Dexamethasone—atopic dermatitis	1.47e-05	0.000202	CcSEcCtD
Fentanyl—Malaise—Betamethasone—atopic dermatitis	1.47e-05	0.000202	CcSEcCtD
Fentanyl—Oedema—Triamcinolone—atopic dermatitis	1.47e-05	0.000201	CcSEcCtD
Fentanyl—Anaphylactic shock—Triamcinolone—atopic dermatitis	1.47e-05	0.000201	CcSEcCtD
Fentanyl—Vertigo—Betamethasone—atopic dermatitis	1.47e-05	0.000201	CcSEcCtD
Fentanyl—Vertigo—Dexamethasone—atopic dermatitis	1.47e-05	0.000201	CcSEcCtD
Fentanyl—Anaphylactic shock—Methylprednisolone—atopic dermatitis	1.47e-05	0.000201	CcSEcCtD
Fentanyl—Syncope—Betamethasone—atopic dermatitis	1.47e-05	0.000201	CcSEcCtD
Fentanyl—Syncope—Dexamethasone—atopic dermatitis	1.47e-05	0.000201	CcSEcCtD
Fentanyl—Arrhythmia—Prednisone—atopic dermatitis	1.46e-05	0.0002	CcSEcCtD
Fentanyl—Infection—Triamcinolone—atopic dermatitis	1.46e-05	0.0002	CcSEcCtD
Fentanyl—Hypotension—Hydrocortisone—atopic dermatitis	1.46e-05	0.0002	CcSEcCtD
Fentanyl—Infection—Methylprednisolone—atopic dermatitis	1.46e-05	0.0002	CcSEcCtD
Fentanyl—OPRD1—Signaling Pathways—CCL27—atopic dermatitis	1.46e-05	0.00168	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CCR3—atopic dermatitis	1.45e-05	0.00168	CbGpPWpGaD
Fentanyl—Shock—Triamcinolone—atopic dermatitis	1.45e-05	0.000198	CcSEcCtD
Fentanyl—Insomnia—Prednisolone—atopic dermatitis	1.45e-05	0.000198	CcSEcCtD
Fentanyl—Alopecia—Prednisone—atopic dermatitis	1.45e-05	0.000198	CcSEcCtD
Fentanyl—Shock—Methylprednisolone—atopic dermatitis	1.44e-05	0.000198	CcSEcCtD
Fentanyl—Nervous system disorder—Methylprednisolone—atopic dermatitis	1.44e-05	0.000197	CcSEcCtD
Fentanyl—Loss of consciousness—Dexamethasone—atopic dermatitis	1.44e-05	0.000197	CcSEcCtD
Fentanyl—Loss of consciousness—Betamethasone—atopic dermatitis	1.44e-05	0.000197	CcSEcCtD
Fentanyl—Paraesthesia—Prednisolone—atopic dermatitis	1.44e-05	0.000197	CcSEcCtD
Fentanyl—Tachycardia—Triamcinolone—atopic dermatitis	1.44e-05	0.000197	CcSEcCtD
Fentanyl—OPRK1—Signaling Pathways—CCL22—atopic dermatitis	1.43e-05	0.00166	CbGpPWpGaD
Fentanyl—Mental disorder—Prednisone—atopic dermatitis	1.43e-05	0.000196	CcSEcCtD
Fentanyl—Tachycardia—Methylprednisolone—atopic dermatitis	1.43e-05	0.000196	CcSEcCtD
Fentanyl—OPRD1—GPCR downstream signaling—NPS—atopic dermatitis	1.43e-05	0.00165	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—TAC1—atopic dermatitis	1.43e-05	0.00165	CbGpPWpGaD
Fentanyl—Skin disorder—Methylprednisolone—atopic dermatitis	1.43e-05	0.000195	CcSEcCtD
Fentanyl—Erythema—Prednisone—atopic dermatitis	1.42e-05	0.000195	CcSEcCtD
Fentanyl—Malnutrition—Prednisone—atopic dermatitis	1.42e-05	0.000195	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	1.42e-05	0.000195	CcSEcCtD
Fentanyl—Hyperhidrosis—Triamcinolone—atopic dermatitis	1.42e-05	0.000195	CcSEcCtD
Fentanyl—Hyperhidrosis—Methylprednisolone—atopic dermatitis	1.42e-05	0.000194	CcSEcCtD
Fentanyl—Convulsion—Betamethasone—atopic dermatitis	1.42e-05	0.000194	CcSEcCtD
Fentanyl—Convulsion—Dexamethasone—atopic dermatitis	1.42e-05	0.000194	CcSEcCtD
Fentanyl—Insomnia—Hydrocortisone—atopic dermatitis	1.41e-05	0.000194	CcSEcCtD
Fentanyl—Hypertension—Betamethasone—atopic dermatitis	1.41e-05	0.000193	CcSEcCtD
Fentanyl—Hypertension—Dexamethasone—atopic dermatitis	1.41e-05	0.000193	CcSEcCtD
Fentanyl—OPRK1—GPCR downstream signaling—CCR3—atopic dermatitis	1.4e-05	0.00162	CbGpPWpGaD
Fentanyl—Paraesthesia—Hydrocortisone—atopic dermatitis	1.4e-05	0.000192	CcSEcCtD
Fentanyl—OPRD1—GPCR downstream signaling—CXCR3—atopic dermatitis	1.4e-05	0.00162	CbGpPWpGaD
Fentanyl—Myalgia—Betamethasone—atopic dermatitis	1.39e-05	0.000191	CcSEcCtD
Fentanyl—Myalgia—Dexamethasone—atopic dermatitis	1.39e-05	0.000191	CcSEcCtD
Fentanyl—OPRM1—TCR Signaling Pathway—IL6—atopic dermatitis	1.39e-05	0.00161	CbGpPWpGaD
Fentanyl—Anxiety—Dexamethasone—atopic dermatitis	1.39e-05	0.00019	CcSEcCtD
Fentanyl—Anxiety—Betamethasone—atopic dermatitis	1.39e-05	0.00019	CcSEcCtD
Fentanyl—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	1.39e-05	0.0016	CbGpPWpGaD
Fentanyl—Discomfort—Dexamethasone—atopic dermatitis	1.38e-05	0.000188	CcSEcCtD
Fentanyl—Discomfort—Betamethasone—atopic dermatitis	1.38e-05	0.000188	CcSEcCtD
Fentanyl—Dyspepsia—Hydrocortisone—atopic dermatitis	1.38e-05	0.000188	CcSEcCtD
Fentanyl—Hypotension—Methylprednisolone—atopic dermatitis	1.37e-05	0.000188	CcSEcCtD
Fentanyl—Pain—Prednisolone—atopic dermatitis	1.37e-05	0.000187	CcSEcCtD
Fentanyl—OPRM1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	1.36e-05	0.00157	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—CCR5—atopic dermatitis	1.36e-05	0.00157	CbGpPWpGaD
Fentanyl—OPRK1—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.36e-05	0.00157	CbGpPWpGaD
Fentanyl—Decreased appetite—Hydrocortisone—atopic dermatitis	1.36e-05	0.000186	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	1.35e-05	0.000185	CcSEcCtD
Fentanyl—Fatigue—Hydrocortisone—atopic dermatitis	1.35e-05	0.000184	CcSEcCtD
Fentanyl—Vision blurred—Prednisone—atopic dermatitis	1.34e-05	0.000184	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	1.34e-05	0.000184	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	1.34e-05	0.000183	CcSEcCtD
Fentanyl—Pain—Hydrocortisone—atopic dermatitis	1.34e-05	0.000183	CcSEcCtD
Fentanyl—Oedema—Betamethasone—atopic dermatitis	1.33e-05	0.000183	CcSEcCtD
Fentanyl—Anaphylactic shock—Betamethasone—atopic dermatitis	1.33e-05	0.000183	CcSEcCtD
Fentanyl—Anaphylactic shock—Dexamethasone—atopic dermatitis	1.33e-05	0.000183	CcSEcCtD
Fentanyl—Oedema—Dexamethasone—atopic dermatitis	1.33e-05	0.000183	CcSEcCtD
Fentanyl—Insomnia—Triamcinolone—atopic dermatitis	1.33e-05	0.000182	CcSEcCtD
Fentanyl—Insomnia—Methylprednisolone—atopic dermatitis	1.33e-05	0.000182	CcSEcCtD
Fentanyl—OPRD1—GPCR downstream signaling—IL5—atopic dermatitis	1.33e-05	0.00153	CbGpPWpGaD
Fentanyl—Infection—Dexamethasone—atopic dermatitis	1.33e-05	0.000182	CcSEcCtD
Fentanyl—Infection—Betamethasone—atopic dermatitis	1.33e-05	0.000182	CcSEcCtD
Fentanyl—OPRM1—Signaling by GPCR—CCL11—atopic dermatitis	1.32e-05	0.00153	CbGpPWpGaD
Fentanyl—Ill-defined disorder—Prednisone—atopic dermatitis	1.32e-05	0.000181	CcSEcCtD
Fentanyl—Paraesthesia—Triamcinolone—atopic dermatitis	1.32e-05	0.000181	CcSEcCtD
Fentanyl—Feeling abnormal—Prednisolone—atopic dermatitis	1.32e-05	0.000181	CcSEcCtD
Fentanyl—Paraesthesia—Methylprednisolone—atopic dermatitis	1.32e-05	0.000181	CcSEcCtD
Fentanyl—Anaemia—Prednisone—atopic dermatitis	1.32e-05	0.00018	CcSEcCtD
Fentanyl—Shock—Dexamethasone—atopic dermatitis	1.31e-05	0.00018	CcSEcCtD
Fentanyl—Shock—Betamethasone—atopic dermatitis	1.31e-05	0.00018	CcSEcCtD
Fentanyl—Dyspnoea—Triamcinolone—atopic dermatitis	1.31e-05	0.00018	CcSEcCtD
Fentanyl—Nervous system disorder—Betamethasone—atopic dermatitis	1.31e-05	0.000179	CcSEcCtD
Fentanyl—Nervous system disorder—Dexamethasone—atopic dermatitis	1.31e-05	0.000179	CcSEcCtD
Fentanyl—Agitation—Prednisone—atopic dermatitis	1.31e-05	0.000179	CcSEcCtD
Fentanyl—OPRD1—Signaling Pathways—CCL17—atopic dermatitis	1.31e-05	0.00151	CbGpPWpGaD
Fentanyl—Thrombocytopenia—Dexamethasone—atopic dermatitis	1.31e-05	0.000179	CcSEcCtD
Fentanyl—Thrombocytopenia—Betamethasone—atopic dermatitis	1.31e-05	0.000179	CcSEcCtD
Fentanyl—OPRM1—Signaling Pathways—FCER2—atopic dermatitis	1.3e-05	0.0015	CbGpPWpGaD
Fentanyl—Tachycardia—Dexamethasone—atopic dermatitis	1.3e-05	0.000178	CcSEcCtD
Fentanyl—Tachycardia—Betamethasone—atopic dermatitis	1.3e-05	0.000178	CcSEcCtD
Fentanyl—OPRD1—Signaling by GPCR—NPS—atopic dermatitis	1.3e-05	0.0015	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—TAC1—atopic dermatitis	1.3e-05	0.0015	CbGpPWpGaD
Fentanyl—Dyspepsia—Triamcinolone—atopic dermatitis	1.29e-05	0.000177	CcSEcCtD
Fentanyl—Dyspepsia—Methylprednisolone—atopic dermatitis	1.29e-05	0.000177	CcSEcCtD
Fentanyl—Hyperhidrosis—Betamethasone—atopic dermatitis	1.29e-05	0.000177	CcSEcCtD
Fentanyl—Hyperhidrosis—Dexamethasone—atopic dermatitis	1.29e-05	0.000177	CcSEcCtD
Fentanyl—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	1.29e-05	0.00149	CbGpPWpGaD
Fentanyl—Feeling abnormal—Hydrocortisone—atopic dermatitis	1.29e-05	0.000176	CcSEcCtD
Fentanyl—Malaise—Prednisone—atopic dermatitis	1.28e-05	0.000176	CcSEcCtD
Fentanyl—Vertigo—Prednisone—atopic dermatitis	1.28e-05	0.000175	CcSEcCtD
Fentanyl—OPRK1—Signaling Pathways—CCL27—atopic dermatitis	1.28e-05	0.00148	CbGpPWpGaD
Fentanyl—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	1.28e-05	0.000175	CcSEcCtD
Fentanyl—Syncope—Prednisone—atopic dermatitis	1.28e-05	0.000175	CcSEcCtD
Fentanyl—OPRM1—GPCR ligand binding—CCL5—atopic dermatitis	1.28e-05	0.00147	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CCR3—atopic dermatitis	1.27e-05	0.00147	CbGpPWpGaD
Fentanyl—Anorexia—Dexamethasone—atopic dermatitis	1.27e-05	0.000174	CcSEcCtD
Fentanyl—Anorexia—Betamethasone—atopic dermatitis	1.27e-05	0.000174	CcSEcCtD
Fentanyl—Urticaria—Prednisolone—atopic dermatitis	1.27e-05	0.000174	CcSEcCtD
Fentanyl—OPRD1—Signaling by GPCR—CXCR3—atopic dermatitis	1.27e-05	0.00147	CbGpPWpGaD
Fentanyl—Fatigue—Triamcinolone—atopic dermatitis	1.27e-05	0.000174	CcSEcCtD
Fentanyl—Fatigue—Methylprednisolone—atopic dermatitis	1.27e-05	0.000173	CcSEcCtD
Fentanyl—Pain—Triamcinolone—atopic dermatitis	1.26e-05	0.000172	CcSEcCtD
Fentanyl—Loss of consciousness—Prednisone—atopic dermatitis	1.25e-05	0.000171	CcSEcCtD
Fentanyl—OPRK1—GPCR downstream signaling—TAC1—atopic dermatitis	1.25e-05	0.00144	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—NPS—atopic dermatitis	1.25e-05	0.00144	CbGpPWpGaD
Fentanyl—Hypotension—Betamethasone—atopic dermatitis	1.25e-05	0.000171	CcSEcCtD
Fentanyl—Hypotension—Dexamethasone—atopic dermatitis	1.25e-05	0.000171	CcSEcCtD
Fentanyl—Urticaria—Hydrocortisone—atopic dermatitis	1.24e-05	0.00017	CcSEcCtD
Fentanyl—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	1.24e-05	0.00143	CbGpPWpGaD
Fentanyl—Abdominal pain—Hydrocortisone—atopic dermatitis	1.23e-05	0.000169	CcSEcCtD
Fentanyl—Body temperature increased—Hydrocortisone—atopic dermatitis	1.23e-05	0.000169	CcSEcCtD
Fentanyl—Convulsion—Prednisone—atopic dermatitis	1.23e-05	0.000169	CcSEcCtD
Fentanyl—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.23e-05	0.00142	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—IL2—atopic dermatitis	1.23e-05	0.00142	CbGpPWpGaD
Fentanyl—Hypertension—Prednisone—atopic dermatitis	1.23e-05	0.000168	CcSEcCtD
Fentanyl—OPRK1—GPCR downstream signaling—CXCR3—atopic dermatitis	1.23e-05	0.00142	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	1.22e-05	0.00141	CbGpPWpGaD
Fentanyl—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	1.22e-05	0.000167	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	1.22e-05	0.000167	CcSEcCtD
Fentanyl—Arthralgia—Prednisone—atopic dermatitis	1.21e-05	0.000166	CcSEcCtD
Fentanyl—Myalgia—Prednisone—atopic dermatitis	1.21e-05	0.000166	CcSEcCtD
Fentanyl—Feeling abnormal—Triamcinolone—atopic dermatitis	1.21e-05	0.000166	CcSEcCtD
Fentanyl—OPRM1—Signaling Pathways—CCL22—atopic dermatitis	1.21e-05	0.0014	CbGpPWpGaD
Fentanyl—Feeling abnormal—Methylprednisolone—atopic dermatitis	1.21e-05	0.000166	CcSEcCtD
Fentanyl—Anxiety—Prednisone—atopic dermatitis	1.21e-05	0.000166	CcSEcCtD
Fentanyl—Insomnia—Dexamethasone—atopic dermatitis	1.21e-05	0.000165	CcSEcCtD
Fentanyl—Insomnia—Betamethasone—atopic dermatitis	1.21e-05	0.000165	CcSEcCtD
Fentanyl—OPRD1—Signaling by GPCR—IL5—atopic dermatitis	1.2e-05	0.00139	CbGpPWpGaD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	1.2e-05	0.000165	CcSEcCtD
Fentanyl—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	1.2e-05	0.000164	CcSEcCtD
Fentanyl—Paraesthesia—Betamethasone—atopic dermatitis	1.2e-05	0.000164	CcSEcCtD
Fentanyl—Paraesthesia—Dexamethasone—atopic dermatitis	1.2e-05	0.000164	CcSEcCtD
Fentanyl—Discomfort—Prednisone—atopic dermatitis	1.2e-05	0.000164	CcSEcCtD
Fentanyl—OPRM1—GPCR downstream signaling—CCR3—atopic dermatitis	1.19e-05	0.00137	CbGpPWpGaD
Fentanyl—Hypersensitivity—Prednisolone—atopic dermatitis	1.18e-05	0.000161	CcSEcCtD
Fentanyl—Dyspepsia—Betamethasone—atopic dermatitis	1.17e-05	0.000161	CcSEcCtD
Fentanyl—Dyspepsia—Dexamethasone—atopic dermatitis	1.17e-05	0.000161	CcSEcCtD
Fentanyl—Urticaria—Triamcinolone—atopic dermatitis	1.17e-05	0.00016	CcSEcCtD
Fentanyl—Urticaria—Methylprednisolone—atopic dermatitis	1.17e-05	0.00016	CcSEcCtD
Fentanyl—OPRD1—Signaling Pathways—KIF3A—atopic dermatitis	1.16e-05	0.00134	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—IL5—atopic dermatitis	1.16e-05	0.00134	CbGpPWpGaD
Fentanyl—Body temperature increased—Triamcinolone—atopic dermatitis	1.16e-05	0.000159	CcSEcCtD
Fentanyl—Anaphylactic shock—Prednisone—atopic dermatitis	1.16e-05	0.000159	CcSEcCtD
Fentanyl—Oedema—Prednisone—atopic dermatitis	1.16e-05	0.000159	CcSEcCtD
Fentanyl—Abdominal pain—Methylprednisolone—atopic dermatitis	1.16e-05	0.000159	CcSEcCtD
Fentanyl—Decreased appetite—Dexamethasone—atopic dermatitis	1.16e-05	0.000159	CcSEcCtD
Fentanyl—Decreased appetite—Betamethasone—atopic dermatitis	1.16e-05	0.000159	CcSEcCtD
Fentanyl—Infection—Prednisone—atopic dermatitis	1.15e-05	0.000158	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Betamethasone—atopic dermatitis	1.15e-05	0.000158	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	1.15e-05	0.000158	CcSEcCtD
Fentanyl—Hypersensitivity—Hydrocortisone—atopic dermatitis	1.15e-05	0.000158	CcSEcCtD
Fentanyl—Fatigue—Betamethasone—atopic dermatitis	1.15e-05	0.000158	CcSEcCtD
Fentanyl—Fatigue—Dexamethasone—atopic dermatitis	1.15e-05	0.000158	CcSEcCtD
Fentanyl—OPRM1—GPCR ligand binding—CCR5—atopic dermatitis	1.15e-05	0.00133	CbGpPWpGaD
Fentanyl—OPRM1—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.15e-05	0.00133	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCL17—atopic dermatitis	1.15e-05	0.00132	CbGpPWpGaD
Fentanyl—Shock—Prednisone—atopic dermatitis	1.14e-05	0.000157	CcSEcCtD
Fentanyl—Pain—Betamethasone—atopic dermatitis	1.14e-05	0.000156	CcSEcCtD
Fentanyl—Pain—Dexamethasone—atopic dermatitis	1.14e-05	0.000156	CcSEcCtD
Fentanyl—Nervous system disorder—Prednisone—atopic dermatitis	1.14e-05	0.000156	CcSEcCtD
Fentanyl—OPRK1—Signaling by GPCR—NPS—atopic dermatitis	1.14e-05	0.00131	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—TAC1—atopic dermatitis	1.14e-05	0.00131	CbGpPWpGaD
Fentanyl—Tachycardia—Prednisone—atopic dermatitis	1.13e-05	0.000155	CcSEcCtD
Fentanyl—OPRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	1.13e-05	0.00131	CbGpPWpGaD
Fentanyl—Skin disorder—Prednisone—atopic dermatitis	1.13e-05	0.000155	CcSEcCtD
Fentanyl—Hyperhidrosis—Prednisone—atopic dermatitis	1.12e-05	0.000154	CcSEcCtD
Fentanyl—Asthenia—Hydrocortisone—atopic dermatitis	1.12e-05	0.000154	CcSEcCtD
Fentanyl—OPRK1—Signaling by GPCR—CXCR3—atopic dermatitis	1.11e-05	0.00129	CbGpPWpGaD
Fentanyl—Anorexia—Prednisone—atopic dermatitis	1.11e-05	0.000152	CcSEcCtD
Fentanyl—Pruritus—Hydrocortisone—atopic dermatitis	1.11e-05	0.000151	CcSEcCtD
Fentanyl—Feeling abnormal—Betamethasone—atopic dermatitis	1.1e-05	0.000151	CcSEcCtD
Fentanyl—Feeling abnormal—Dexamethasone—atopic dermatitis	1.1e-05	0.000151	CcSEcCtD
Fentanyl—Gastrointestinal pain—Betamethasone—atopic dermatitis	1.09e-05	0.00015	CcSEcCtD
Fentanyl—Gastrointestinal pain—Dexamethasone—atopic dermatitis	1.09e-05	0.00015	CcSEcCtD
Fentanyl—Hypersensitivity—Triamcinolone—atopic dermatitis	1.08e-05	0.000148	CcSEcCtD
Fentanyl—Hypersensitivity—Methylprednisolone—atopic dermatitis	1.08e-05	0.000148	CcSEcCtD
Fentanyl—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.08e-05	0.00125	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCL27—atopic dermatitis	1.08e-05	0.00125	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CCR3—atopic dermatitis	1.08e-05	0.00124	CbGpPWpGaD
Fentanyl—Diarrhoea—Hydrocortisone—atopic dermatitis	1.07e-05	0.000146	CcSEcCtD
Fentanyl—Urticaria—Betamethasone—atopic dermatitis	1.06e-05	0.000145	CcSEcCtD
Fentanyl—Urticaria—Dexamethasone—atopic dermatitis	1.06e-05	0.000145	CcSEcCtD
Fentanyl—CYP3A7—Metabolism—GLB1—atopic dermatitis	1.06e-05	0.00122	CbGpPWpGaD
Fentanyl—Musculoskeletal discomfort—Prednisone—atopic dermatitis	1.06e-05	0.000145	CcSEcCtD
Fentanyl—Dizziness—Prednisolone—atopic dermatitis	1.06e-05	0.000145	CcSEcCtD
Fentanyl—OPRM1—GPCR downstream signaling—TAC1—atopic dermatitis	1.06e-05	0.00122	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—NPS—atopic dermatitis	1.06e-05	0.00122	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL5—atopic dermatitis	1.06e-05	0.00122	CbGpPWpGaD
Fentanyl—Asthenia—Triamcinolone—atopic dermatitis	1.06e-05	0.000145	CcSEcCtD
Fentanyl—Abdominal pain—Betamethasone—atopic dermatitis	1.06e-05	0.000145	CcSEcCtD
Fentanyl—Abdominal pain—Dexamethasone—atopic dermatitis	1.06e-05	0.000145	CcSEcCtD
Fentanyl—Body temperature increased—Dexamethasone—atopic dermatitis	1.06e-05	0.000145	CcSEcCtD
Fentanyl—Body temperature increased—Betamethasone—atopic dermatitis	1.06e-05	0.000145	CcSEcCtD
Fentanyl—OPRD1—Signaling Pathways—CCL11—atopic dermatitis	1.05e-05	0.00122	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CMA1—atopic dermatitis	1.05e-05	0.00122	CbGpPWpGaD
Fentanyl—Asthenia—Methylprednisolone—atopic dermatitis	1.05e-05	0.000144	CcSEcCtD
Fentanyl—Insomnia—Prednisone—atopic dermatitis	1.05e-05	0.000144	CcSEcCtD
Fentanyl—Paraesthesia—Prednisone—atopic dermatitis	1.04e-05	0.000143	CcSEcCtD
Fentanyl—Pruritus—Triamcinolone—atopic dermatitis	1.04e-05	0.000143	CcSEcCtD
Fentanyl—Pruritus—Methylprednisolone—atopic dermatitis	1.04e-05	0.000142	CcSEcCtD
Fentanyl—OPRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	1.04e-05	0.0012	CbGpPWpGaD
Fentanyl—Dizziness—Hydrocortisone—atopic dermatitis	1.03e-05	0.000142	CcSEcCtD
Fentanyl—OPRD1—Signaling by GPCR—CXCL10—atopic dermatitis	1.03e-05	0.00119	CbGpPWpGaD
Fentanyl—Dyspepsia—Prednisone—atopic dermatitis	1.02e-05	0.00014	CcSEcCtD
Fentanyl—OPRK1—Signaling Pathways—KIF3A—atopic dermatitis	1.02e-05	0.00118	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ADSL—atopic dermatitis	1.02e-05	0.00117	CbGpPWpGaD
Fentanyl—Decreased appetite—Prednisone—atopic dermatitis	1.01e-05	0.000138	CcSEcCtD
Fentanyl—Rash—Prednisolone—atopic dermatitis	1.01e-05	0.000138	CcSEcCtD
Fentanyl—Dermatitis—Prednisolone—atopic dermatitis	1.01e-05	0.000138	CcSEcCtD
Fentanyl—Diarrhoea—Methylprednisolone—atopic dermatitis	1e-05	0.000138	CcSEcCtD
Fentanyl—Fatigue—Prednisone—atopic dermatitis	1e-05	0.000137	CcSEcCtD
Fentanyl—Headache—Prednisolone—atopic dermatitis	1e-05	0.000137	CcSEcCtD
Fentanyl—Constipation—Prednisone—atopic dermatitis	9.94e-06	0.000136	CcSEcCtD
Fentanyl—Vomiting—Hydrocortisone—atopic dermatitis	9.93e-06	0.000136	CcSEcCtD
Fentanyl—OPRK1—GPCR downstream signaling—CXCL10—atopic dermatitis	9.92e-06	0.00115	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—STAT6—atopic dermatitis	9.9e-06	0.00114	CbGpPWpGaD
Fentanyl—Rash—Hydrocortisone—atopic dermatitis	9.85e-06	0.000135	CcSEcCtD
Fentanyl—Dermatitis—Hydrocortisone—atopic dermatitis	9.84e-06	0.000135	CcSEcCtD
Fentanyl—OPRM1—GPCR downstream signaling—IL5—atopic dermatitis	9.83e-06	0.00113	CbGpPWpGaD
Fentanyl—Headache—Hydrocortisone—atopic dermatitis	9.79e-06	0.000134	CcSEcCtD
Fentanyl—OPRD1—GPCR downstream signaling—CCL5—atopic dermatitis	9.74e-06	0.00112	CbGpPWpGaD
Fentanyl—Dizziness—Triamcinolone—atopic dermatitis	9.73e-06	0.000133	CcSEcCtD
Fentanyl—Dizziness—Methylprednisolone—atopic dermatitis	9.71e-06	0.000133	CcSEcCtD
Fentanyl—OPRM1—Signaling Pathways—CCL17—atopic dermatitis	9.68e-06	0.00112	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—NPS—atopic dermatitis	9.6e-06	0.00111	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—TAC1—atopic dermatitis	9.6e-06	0.00111	CbGpPWpGaD
Fentanyl—Feeling abnormal—Prednisone—atopic dermatitis	9.58e-06	0.000131	CcSEcCtD
Fentanyl—Asthenia—Betamethasone—atopic dermatitis	9.58e-06	0.000131	CcSEcCtD
Fentanyl—Asthenia—Dexamethasone—atopic dermatitis	9.58e-06	0.000131	CcSEcCtD
Fentanyl—Gastrointestinal pain—Prednisone—atopic dermatitis	9.5e-06	0.00013	CcSEcCtD
Fentanyl—Nausea—Prednisolone—atopic dermatitis	9.5e-06	0.00013	CcSEcCtD
Fentanyl—Pruritus—Betamethasone—atopic dermatitis	9.44e-06	0.000129	CcSEcCtD
Fentanyl—Pruritus—Dexamethasone—atopic dermatitis	9.44e-06	0.000129	CcSEcCtD
Fentanyl—OPRM1—Signaling by GPCR—CXCR3—atopic dermatitis	9.42e-06	0.00109	CbGpPWpGaD
Fentanyl—OPRD1—GPCR ligand binding—CXCL8—atopic dermatitis	9.38e-06	0.00108	CbGpPWpGaD
Fentanyl—Vomiting—Triamcinolone—atopic dermatitis	9.35e-06	0.000128	CcSEcCtD
Fentanyl—Vomiting—Methylprednisolone—atopic dermatitis	9.33e-06	0.000128	CcSEcCtD
Fentanyl—Nausea—Hydrocortisone—atopic dermatitis	9.28e-06	0.000127	CcSEcCtD
Fentanyl—Rash—Triamcinolone—atopic dermatitis	9.27e-06	0.000127	CcSEcCtD
Fentanyl—Dermatitis—Triamcinolone—atopic dermatitis	9.27e-06	0.000127	CcSEcCtD
Fentanyl—Rash—Methylprednisolone—atopic dermatitis	9.25e-06	0.000127	CcSEcCtD
Fentanyl—Dermatitis—Methylprednisolone—atopic dermatitis	9.25e-06	0.000127	CcSEcCtD
Fentanyl—OPRK1—Signaling Pathways—CMA1—atopic dermatitis	9.24e-06	0.00107	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCL11—atopic dermatitis	9.24e-06	0.00107	CbGpPWpGaD
Fentanyl—Urticaria—Prednisone—atopic dermatitis	9.23e-06	0.000126	CcSEcCtD
Fentanyl—Headache—Triamcinolone—atopic dermatitis	9.22e-06	0.000126	CcSEcCtD
Fentanyl—Headache—Methylprednisolone—atopic dermatitis	9.19e-06	0.000126	CcSEcCtD
Fentanyl—Body temperature increased—Prednisone—atopic dermatitis	9.19e-06	0.000126	CcSEcCtD
Fentanyl—Abdominal pain—Prednisone—atopic dermatitis	9.19e-06	0.000126	CcSEcCtD
Fentanyl—Diarrhoea—Betamethasone—atopic dermatitis	9.13e-06	0.000125	CcSEcCtD
Fentanyl—Diarrhoea—Dexamethasone—atopic dermatitis	9.13e-06	0.000125	CcSEcCtD
Fentanyl—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	9.13e-06	0.00105	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CXCL10—atopic dermatitis	9.01e-06	0.00104	CbGpPWpGaD
Fentanyl—ABCB1—Allograft Rejection—TNF—atopic dermatitis	8.97e-06	0.00104	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL5—atopic dermatitis	8.93e-06	0.00103	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	8.92e-06	0.00103	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CCL5—atopic dermatitis	8.84e-06	0.00102	CbGpPWpGaD
Fentanyl—Dizziness—Dexamethasone—atopic dermatitis	8.83e-06	0.000121	CcSEcCtD
Fentanyl—Dizziness—Betamethasone—atopic dermatitis	8.83e-06	0.000121	CcSEcCtD
Fentanyl—OPRD1—GPCR downstream signaling—CCR5—atopic dermatitis	8.77e-06	0.00101	CbGpPWpGaD
Fentanyl—Nausea—Triamcinolone—atopic dermatitis	8.74e-06	0.00012	CcSEcCtD
Fentanyl—Nausea—Methylprednisolone—atopic dermatitis	8.72e-06	0.000119	CcSEcCtD
Fentanyl—OPRK1—Signaling Pathways—STAT6—atopic dermatitis	8.68e-06	0.001	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KIF3A—atopic dermatitis	8.63e-06	0.000997	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCR3—atopic dermatitis	8.59e-06	0.000991	CbGpPWpGaD
Fentanyl—Hypersensitivity—Prednisone—atopic dermatitis	8.56e-06	0.000117	CcSEcCtD
Fentanyl—OPRK1—GPCR downstream signaling—CCL5—atopic dermatitis	8.54e-06	0.000986	CbGpPWpGaD
Fentanyl—Vomiting—Dexamethasone—atopic dermatitis	8.49e-06	0.000116	CcSEcCtD
Fentanyl—Vomiting—Betamethasone—atopic dermatitis	8.49e-06	0.000116	CcSEcCtD
Fentanyl—Rash—Dexamethasone—atopic dermatitis	8.42e-06	0.000115	CcSEcCtD
Fentanyl—Rash—Betamethasone—atopic dermatitis	8.42e-06	0.000115	CcSEcCtD
Fentanyl—Dermatitis—Dexamethasone—atopic dermatitis	8.41e-06	0.000115	CcSEcCtD
Fentanyl—Dermatitis—Betamethasone—atopic dermatitis	8.41e-06	0.000115	CcSEcCtD
Fentanyl—OPRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	8.38e-06	0.000968	CbGpPWpGaD
Fentanyl—Headache—Dexamethasone—atopic dermatitis	8.36e-06	0.000115	CcSEcCtD
Fentanyl—Headache—Betamethasone—atopic dermatitis	8.36e-06	0.000115	CcSEcCtD
Fentanyl—Asthenia—Prednisone—atopic dermatitis	8.34e-06	0.000114	CcSEcCtD
Fentanyl—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	8.27e-06	0.000954	CbGpPWpGaD
Fentanyl—OPRK1—GPCR ligand binding—CXCL8—atopic dermatitis	8.23e-06	0.00095	CbGpPWpGaD
Fentanyl—Pruritus—Prednisone—atopic dermatitis	8.22e-06	0.000113	CcSEcCtD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	8.04e-06	0.000929	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CCR5—atopic dermatitis	7.96e-06	0.00092	CbGpPWpGaD
Fentanyl—Diarrhoea—Prednisone—atopic dermatitis	7.95e-06	0.000109	CcSEcCtD
Fentanyl—Nausea—Betamethasone—atopic dermatitis	7.93e-06	0.000109	CcSEcCtD
Fentanyl—Nausea—Dexamethasone—atopic dermatitis	7.93e-06	0.000109	CcSEcCtD
Fentanyl—OPRM1—Signaling Pathways—CCL11—atopic dermatitis	7.81e-06	0.000901	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CMA1—atopic dermatitis	7.81e-06	0.000901	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CCL5—atopic dermatitis	7.75e-06	0.000895	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CCR5—atopic dermatitis	7.69e-06	0.000888	CbGpPWpGaD
Fentanyl—Dizziness—Prednisone—atopic dermatitis	7.69e-06	0.000105	CcSEcCtD
Fentanyl—CYP3A5—Metabolism—GLB1—atopic dermatitis	7.66e-06	0.000884	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NPS—atopic dermatitis	7.65e-06	0.000884	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TAC1—atopic dermatitis	7.65e-06	0.000884	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CXCL10—atopic dermatitis	7.61e-06	0.000879	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCR3—atopic dermatitis	7.53e-06	0.000869	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CXCR3—atopic dermatitis	7.51e-06	0.000867	CbGpPWpGaD
Fentanyl—Vomiting—Prednisone—atopic dermatitis	7.39e-06	0.000101	CcSEcCtD
Fentanyl—CYP3A5—Metabolism—ADSL—atopic dermatitis	7.34e-06	0.000848	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—STAT6—atopic dermatitis	7.34e-06	0.000847	CbGpPWpGaD
Fentanyl—Rash—Prednisone—atopic dermatitis	7.33e-06	0.0001	CcSEcCtD
Fentanyl—Dermatitis—Prednisone—atopic dermatitis	7.32e-06	0.0001	CcSEcCtD
Fentanyl—Headache—Prednisone—atopic dermatitis	7.28e-06	9.97e-05	CcSEcCtD
Fentanyl—OPRM1—GPCR downstream signaling—CCL5—atopic dermatitis	7.21e-06	0.000833	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL5—atopic dermatitis	7.12e-06	0.000822	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CCR5—atopic dermatitis	6.98e-06	0.000806	CbGpPWpGaD
Fentanyl—OPRM1—GPCR ligand binding—CXCL8—atopic dermatitis	6.95e-06	0.000803	CbGpPWpGaD
Fentanyl—Nausea—Prednisone—atopic dermatitis	6.9e-06	9.46e-05	CcSEcCtD
Fentanyl—OPRK1—Signaling Pathways—TAC1—atopic dermatitis	6.71e-06	0.000775	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NPS—atopic dermatitis	6.71e-06	0.000775	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CXCR3—atopic dermatitis	6.58e-06	0.00076	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CCL5—atopic dermatitis	6.55e-06	0.000756	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CCR5—atopic dermatitis	6.5e-06	0.00075	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCR3—atopic dermatitis	6.36e-06	0.000735	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL5—atopic dermatitis	6.24e-06	0.00072	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CXCL10—atopic dermatitis	6.07e-06	0.0007	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CCR5—atopic dermatitis	5.9e-06	0.000682	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GLB1—atopic dermatitis	5.78e-06	0.000667	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TAC1—atopic dermatitis	5.67e-06	0.000655	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NPS—atopic dermatitis	5.67e-06	0.000655	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	5.59e-06	0.000646	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CXCR3—atopic dermatitis	5.56e-06	0.000642	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ADSL—atopic dermatitis	5.54e-06	0.00064	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CXCL10—atopic dermatitis	5.32e-06	0.000614	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	5.3e-06	0.000612	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL5—atopic dermatitis	5.27e-06	0.000609	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCL5—atopic dermatitis	5.22e-06	0.000603	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—IL2—atopic dermatitis	5.07e-06	0.000585	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NGF—atopic dermatitis	4.84e-06	0.000558	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CXCL8—atopic dermatitis	4.82e-06	0.000556	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCR5—atopic dermatitis	4.7e-06	0.000543	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.65e-06	0.000537	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL2—atopic dermatitis	4.6e-06	0.000531	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCL5—atopic dermatitis	4.58e-06	0.000529	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CXCL10—atopic dermatitis	4.5e-06	0.000519	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—IL2—atopic dermatitis	4.44e-06	0.000513	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	4.43e-06	0.000511	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NGF—atopic dermatitis	4.24e-06	0.00049	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CXCL8—atopic dermatitis	4.22e-06	0.000488	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCR5—atopic dermatitis	4.13e-06	0.000476	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL2—atopic dermatitis	4.04e-06	0.000466	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	4e-06	0.000462	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NFKBIA—atopic dermatitis	3.99e-06	0.000461	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	3.93e-06	0.000454	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCL5—atopic dermatitis	3.87e-06	0.000447	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—IL2—atopic dermatitis	3.76e-06	0.000434	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NGF—atopic dermatitis	3.58e-06	0.000414	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CXCL8—atopic dermatitis	3.57e-06	0.000412	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GLB1—atopic dermatitis	3.56e-06	0.000411	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NFKBIA—atopic dermatitis	3.5e-06	0.000404	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCR5—atopic dermatitis	3.49e-06	0.000403	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PPARA—atopic dermatitis	3.44e-06	0.000397	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.41e-06	0.000394	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL2—atopic dermatitis	3.41e-06	0.000394	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NFKBIA—atopic dermatitis	2.96e-06	0.000341	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CXCL8—atopic dermatitis	2.84e-06	0.000328	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL2—atopic dermatitis	2.72e-06	0.000314	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL6—atopic dermatitis	2.7e-06	0.000312	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MAPK8—atopic dermatitis	2.5e-06	0.000289	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CXCL8—atopic dermatitis	2.49e-06	0.000288	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARA—atopic dermatitis	2.49e-06	0.000287	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL2—atopic dermatitis	2.38e-06	0.000275	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL6—atopic dermatitis	2.37e-06	0.000274	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MAPK8—atopic dermatitis	2.19e-06	0.000253	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CXCL8—atopic dermatitis	2.11e-06	0.000243	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL2—atopic dermatitis	2.01e-06	0.000233	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL6—atopic dermatitis	2e-06	0.000231	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARA—atopic dermatitis	1.88e-06	0.000217	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAPK8—atopic dermatitis	1.85e-06	0.000214	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL6—atopic dermatitis	1.6e-06	0.000184	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6—atopic dermatitis	1.4e-06	0.000162	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6—atopic dermatitis	1.18e-06	0.000137	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.16e-06	0.000133	CbGpPWpGaD
